POINT Biopharma Global Inc.

POINT Biopharma Global Inc. came to market through GX Acquisition Corp. II, a blank-check company that traded under the ticker RACA and was sponsored by GX Sponsor II LLC. The SPAC completed its initial public offering in 2020, targeting the healthcare and life sciences sector. An 8-K filed on July 1, 2021, reported on the consummation of the business combination between GX Acquisition Corp. II and POINT Biopharma, a clinical-stage radiopharmaceutical company focused on cancer therapeutics, marking the close of the de-SPAC transaction. The combined company subsequently began trading under the ticker PNT. For complete filing history, deal terms, and sponsor details on RACA and thousands of other SPAC transactions, sign up for full data access at SpacDesk.